Sharp Therapeutics Corp.
SHRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.70K | 104.70K | 956.60K | 1.99M | 3.15M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 45.00K | 45.00K | 58.60K | 77.40K | 86.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 149.70K | 149.70K | 1.02M | 2.07M | 3.24M |
|
|
|||||
| Total Current Assets | 149.70K | 149.70K | 1.02M | 2.07M | 3.24M |
| Net Property, Plant & Equipment | 875.80K | 875.80K | 920.00K | 943.20K | 968.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.70K | 16.70K | 16.70K | 16.70K | 16.70K |
| Total Assets | 1.04M | 1.04M | 1.95M | 3.03M | 4.22M |
|
|
|||||
| Total Accounts Payable | 268.40K | 268.40K | 294.50K | 209.50K | 346.80K |
| Total Accrued Expenses | 697.60K | 697.60K | 551.50K | 113.30K | 117.40K |
| Short-term Debt | 1.01M | 1.01M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 218.40K | 218.40K | 108.60K | 108.20K | 48.10K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 0.00 |
| Total Other Current Liabilities | -- | -- | -- | -- | 0.00 |
| Total Current Liabilities | 2.19M | 2.19M | 954.60K | 431.10K | 512.30K |
|
|
|||||
| Total Current Liabilities | 2.19M | 2.19M | 954.60K | 431.10K | 512.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.01M | 1.01M | -- | -- | -- |
| Capital Leases | 1.03M | 1.03M | 1.17M | 1.18M | 1.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00 | -- |
| Total Liabilities | 3.22M | 3.22M | 2.13M | 1.61M | 1.76M |
|
|
|||||
| Common Stock & APIC | 26.37M | 26.37M | 25.92M | 25.02M | 25.01M |
| Retained Earnings | -28.51M | -28.51M | -26.06M | -23.64M | -22.58M |
| Treasury Stock & Other | -44.60K | -44.60K | -37.90K | 33.90K | 26.00K |
| Total Common Equity | -2.18M | -2.18M | -176.60K | 1.42M | 2.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.18M | -2.18M | -176.60K | 1.42M | 2.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.18M | -2.18M | -176.60K | 1.42M | 2.46M |
|
|
|||||